Malignant Head and Neck Neoplasm — Trials

Malignant Head and Neck Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,448 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,431
Recruiting: 781
Ph III recruiting: 109
Growth YoY: +20.1%
Industry share: 18%
Top sponsor: Sun Yat-sen University
Termination share: 29.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (629)

clinicaltrialsPublishedShowing 51–60 of 60 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00365508	Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking	completed	Phase 4	642	Fox Chase Cancer CenterOTHER	1	Mar 29, 2016	clinicaltrials
NCT02293356	Phase IV Clinical Trial of Nimotuzumab in the Treatment of Nasopharyngeal Carcinoma	unknown	Phase 4	2,000	Biotech Pharmaceutical Co., Ltd.OTHER	1	Aug 19, 2015	clinicaltrials